 WAYNE, Pa. and ROCKVILLE, Md., March 08, 2022 GLOBE NEWSWIRE -- Avalo Therapeutics, Inc. Nasdaq: AVTX, a leading clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical need in immunology and rare genetic diseases, announced today that members of its senior management team will present at Oppenheimers 32nd Annual Healthcare Conference on Wednesday, March 16, 2022 at 1:20 p.m. ET. 